Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.999
Filter
1.
Aust J Gen Pract ; 53(6): 341, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38840371
3.
Int J Rheum Dis ; 27(6): e15181, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38831523

ABSTRACT

OBJECTIVES: Sleep disturbance is common in autoimmune rheumatism diseases (ARD) and it plays an important role in activating disease and affects the quality of life. This study aims to evaluate the efficacy and acceptability of the novel electrical therapy on sleep disturbance in ARD patients and its effect on immunologic factors. METHODS: A total of 51 ARD patients (26 treatment group and 25 control group) with sleep disturbance were enrolled in this study. Sleep parameters and immunological indicators (serum level of 12 cytokines and immune function) were collected. The novel electrical therapy was prescribed for 15-30 min 3-6 times a day. The Pittsburg Sleep Index (PSQI) was assessed before and after 3 months' treatment by Mi Energy equipment. Immune function and serum levels of cytokines of all participants at baseline and after treatment were tested with flow cytometry and flow immunofluorescence, respectively. Correlation analysis was used to analyze the relationship between sleep disturbance and immunologic factors. Multiple linear regression analysis was employed to investigate the risk of sleep disturbance in ARD. RESULTS: The global score of PSQI (Baseline: 12.81 ± 4.07, After novel electrical therapy: 4.88 ± 2.76) was effectively improved after 3 months of adjuvant therapy by electrical therapy. We also found that serum levels of IL-8 and IL-1ß statistically significantly decreased after novel electrical therapy. This adjuvant therapy can also significantly decrease the percentage of CD4 + CD8 + T cell, effector memory CD8 + T cell, Memory CD8 + T cell, Th17 cell, and plasma cell and significantly can increase the percentage of naïve CD8 + T cell, Th2 cell, and Tfh2 cell. Nevertheless, all serum level of 12 cytokines and the percentage of immune cells did not correlate with the PSQI global score except the Tc17 cell. Furthermore, age is an independent risk factor influencing PSQI scores (OR = 1.15, p < 0.05) in patients with autoimmune diseases through multiple linear regression analysis. CONCLUSIONS: Novel electrical therapy can effectively improve sleep disturbance in patients with ARD. It can also change the serum level of some cytokines (IL-8 and IL-1ß) and percentage of immune cells (CD4 + CD8 + T cell, effector memory CD8 + T cell, Memory CD8 + T cell, Th17 cell, naïve CD8 + T cell, Th2 cell, Tfh2 cell, and plasma cell).


Subject(s)
Autoimmune Diseases , Rheumatic Diseases , Sleep Wake Disorders , Humans , Female , Male , Rheumatic Diseases/therapy , Rheumatic Diseases/immunology , Rheumatic Diseases/blood , Rheumatic Diseases/complications , Middle Aged , Sleep Wake Disorders/etiology , Sleep Wake Disorders/blood , Sleep Wake Disorders/therapy , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathology , Autoimmune Diseases/blood , Autoimmune Diseases/therapy , Autoimmune Diseases/diagnosis , Autoimmune Diseases/complications , Autoimmune Diseases/immunology , Adult , Treatment Outcome , Time Factors , Electric Stimulation Therapy/methods , Biomarkers/blood , Sleep , Cytokines/blood , Case-Control Studies , Sleep Quality
4.
Aust J Gen Pract ; 53(6): 371-378, 2024 06.
Article in English | MEDLINE | ID: mdl-38840375

ABSTRACT

BACKGROUND: Healthy sleep is vital for optimal child development, yet over 30% of Australian parents report having children with disrupted sleep affecting all family members. These sleep difficulties might co-exist with sleep breathing disorders, contributing to morbidity and reduced quality of life. OBJECTIVE: This article aims to provide general practitioners (GPs) with an evidence-based, biopsychosocial approach to managing common sleep problems in infants and preschool-aged children. DISCUSSION: Strategies and techniques are outlined to aid GPs in promoting healthy sleep during infancy, educating parents on typical sleep patterns and supporting families in managing problematic sleep patterns in toddlers. Emphasis is placed on a tailored approach to developing a healthy sleep environment to meet the child's needs and parental values. Valuable resources and indications for specialist consultation are included.


Subject(s)
Sleep Wake Disorders , Humans , Infant , Child, Preschool , Australia , Sleep Wake Disorders/therapy , Sleep Wake Disorders/physiopathology , Parents/psychology , Sleep/physiology , Quality of Life/psychology
5.
Aust J Gen Pract ; 53(6): 379-386, 2024 06.
Article in English | MEDLINE | ID: mdl-38840376

ABSTRACT

BACKGROUND: Adolescence is a stage of significant transition as children develop into young adults. Optimal sleep is crucial during this period to ensure physical, emotional and mental wellbeing. However, it is well recognised that insufficient quality and quantity of sleep is common among adolescents worldwide. OBJECTIVE: This article aims to provide general practitioners with an overview of the key issues encountered in adolescent patients relating to sleep and summarises approaches to assessment and evidence-based management of sleep problems in this population. DISCUSSION: This review highlights the physiological changes that affect sleep during adolescence and how other factors, including unhealthy sleep behaviours, influence these. It discusses the importance of healthy sleep and the consequences of sleep disturbance in adolescents. Management strategies are outlined, focusing on the key common issues that affect sleep in the teenage years, and guidance on when to consider co-management with specialist care is provided.


Subject(s)
Sleep , Humans , Adolescent , Sleep/physiology , Sleep Wake Disorders/therapy , Sleep Wake Disorders/physiopathology
6.
Aust J Gen Pract ; 53(6): 389-393, 2024 06.
Article in English | MEDLINE | ID: mdl-38840377

ABSTRACT

BACKGROUND: Shift work is characterised by displaced sleep opportunities and associated sleep disturbance. Shift workers often report sleepiness and other wake time symptoms associated with poor sleep. However, clinical sleep disorders are also prevalent in shift workers. Although prevalence rates are similar or higher in shift workers compared with the general population, help seeking in shift workers with sleep disorders is low. OBJECTIVE: This article aims to provide general practitioners with a contemporary overview of the prevalence rates for sleep disorders in shift workers, to clarify the existing evidence relating to mental and physical health consequences of sleep disorders in shift workers and to highlight the need to consider undiagnosed sleep disorders before attributing sleep-related symptoms solely to work schedules. DISCUSSION: Symptoms of sleep loss associated with shift work overlap with symptoms experienced by individuals living with sleep disorders. Although >40% of middle-aged Australians live with a sleep disorder that requires investigation and management, symptoms in shift workers are often attributed to the work schedule and, as a result, might not be investigated for appropriate diagnosis and treatment. We argue that screening for sleep disorders in shift workers with sleep complaints should be a priority.


Subject(s)
General Practice , Sleep Wake Disorders , Humans , Sleep Wake Disorders/therapy , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/diagnosis , Australia/epidemiology , General Practice/methods , Sleep Disorders, Circadian Rhythm/therapy , Sleep Disorders, Circadian Rhythm/physiopathology , Sleep Disorders, Circadian Rhythm/diagnosis , Sleep Disorders, Circadian Rhythm/complications , Prevalence , Shift Work Schedule/adverse effects , Work Schedule Tolerance/physiology
8.
Psychosom Med ; 86(4): 283-288, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38724037

ABSTRACT

OBJECTIVE: Sleep disturbance is a "hallmark" symptom of posttraumatic stress disorder (PTSD). Poor sleep (including short sleep) after combat-related trauma can also predict subsequent PTSD. Less is known about the association between sleep duration and PTSD symptoms when PTSD is induced by acute coronary syndrome (ACS). We examined the bidirectional relationship between sleep duration and PTSD symptoms over the year after hospital evaluation for ACS. METHODS: Participants were enrolled in this observational study after emergency department evaluation for ACS. Sleep duration ("During the past month, how many hours of actual sleep did you get at night?") and cardiac event or hospitalization-induced PTSD symptoms (PTSD Checklist) were assessed at 1, 6, and 12 months after hospital discharge. Cross-lagged path analysis was used to model the effects of sleep duration and PTSD symptoms on each other. Covariates included age, sex, race/ethnicity, cardiac severity, baseline depression symptoms, and early acute stress disorder symptoms. RESULTS: The sample included 1145 participants; 16% screened positive for probable PTSD (PTSD Checklist score ≥33). Mean sleep duration across time points was 6.1 hours. Higher PTSD symptoms predicted shorter sleep duration at the next time point (i.e., 1-6 and 6-12 months; B = -0.14 hours/10-point difference, SE = 0.03, p < .001). Shorter sleep duration was associated with higher PTSD symptoms at the next time point (B = -0.25 points/hour, SE = 0.12, p = .04). CONCLUSIONS: Short sleep duration and PTSD symptoms are mutually reinforcing across the first year after ACS evaluation. Findings suggest that sleep, PTSD symptoms, and their relationship should be considered in the post-ACS period.


Subject(s)
Acute Coronary Syndrome , Stress Disorders, Post-Traumatic , Humans , Stress Disorders, Post-Traumatic/physiopathology , Acute Coronary Syndrome/physiopathology , Male , Female , Middle Aged , Aged , Sleep Wake Disorders/etiology , Sleep Wake Disorders/physiopathology , Prospective Studies , Time Factors , Adult , Sleep/physiology , Sleep Duration
9.
J Psychiatr Res ; 174: 332-339, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38697012

ABSTRACT

Electroencephalographic (EEG) deficits in slow wave activity or Delta power (0.5-4 Hz) indicate disturbed sleep homeostasis and are hallmarks of depression. Sleep homeostasis is linked to restorative sleep and potential antidepressant response via non-rapid eye movement (NREM) slow wave sleep (SWS) during which neurons undergo essential repair and rejuvenation. Decreased Low Delta power (0.5-2 Hz) was previously reported in individuals with depression. This study investigated power levels in the Low Delta (0.5-<2 Hz), High Delta (2-4 Hz), and Total Delta (0.5-4 Hz) bands and their association with age, sex, and disrupted sleep in treatment-resistant depression (TRD). Mann-Whitney U tests were used to compare the nightly progressions of Total Delta, Low Delta, and High Delta in 100 individuals with TRD and 24 healthy volunteers (HVs). Polysomnographic parameters were also examined, including Total Sleep Time (TST), Sleep Efficiency (SE), and Wake after Sleep Onset (WASO). Individuals with TRD had lower Delta power during the first NREM episode (NREM1) than HVs. The deficiency was observed in the Low Delta band versus High Delta. Females with TRD had higher Delta power than males during the first NREM1 episode, with the most noticeable sex difference observed in Low Delta. In individuals with TRD, Low Delta power correlated with WASO and SE, and High Delta correlated with WASO. Low Delta power deficits in NREM1 were observed in older males with TRD, but not females. These results provide compelling evidence for a link between age, sex, Low Delta power, sleep homeostasis, and non-restorative sleep in TRD.


Subject(s)
Delta Rhythm , Depressive Disorder, Treatment-Resistant , Electroencephalography , Polysomnography , Humans , Female , Male , Middle Aged , Adult , Depressive Disorder, Treatment-Resistant/physiopathology , Delta Rhythm/physiology , Aged , Sex Characteristics , Young Adult , Sleep Wake Disorders/physiopathology , Sleep/physiology
10.
Respir Med ; 227: 107641, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38710399

ABSTRACT

BACKGROUND: Disturbed sleep in patients with COPD impact quality of life and predict adverse outcomes. RESEARCH QUESTION: To identify distinct phenotypic clusters of patients with COPD using objective sleep parameters and evaluate the associations between clusters and all-cause mortality to inform risk stratification. STUDY DESIGN AND METHODS: A longitudinal observational cohort study using nationwide Veterans Health Administration data of patients with COPD investigated for sleep disorders. Sleep parameters were extracted from polysomnography physician interpretation using a validated natural language processing algorithm. We performed cluster analysis using an unsupervised machine learning algorithm (K-means) and examined the association between clusters and mortality using Cox regression analysis, adjusted for potential confounders, and visualized with Kaplan-Meier estimates. RESULTS: Among 9992 patients with COPD and a clinically indicated baseline polysomnogram, we identified five distinct clusters based on age, comorbidity burden and sleep parameters. Overall mortality increased from 9.4 % to 42 % and short-term mortality (<5.3 years) ranged from 3.4 % to 24.3 % in Cluster 1 to 5. In Cluster 1 younger age, in 5 high comorbidity burden and in the other three clusters, total sleep time and sleep efficiency had significant associations with mortality. INTERPRETATION: We identified five distinct clinical clusters and highlighted the significant association between total sleep time and sleep efficiency on mortality. The identified clusters highlight the importance of objective sleep parameters in determining mortality risk and phenotypic characterization in this population.


Subject(s)
Machine Learning , Phenotype , Polysomnography , Pulmonary Disease, Chronic Obstructive , Sleep Wake Disorders , Humans , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/mortality , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/epidemiology , Cluster Analysis , Male , Female , Aged , Longitudinal Studies , Middle Aged , Sleep Wake Disorders/epidemiology , Sleep Wake Disorders/physiopathology , Polysomnography/methods , Sleep/physiology , Comorbidity , Quality of Life , Unsupervised Machine Learning , Age Factors , Cohort Studies
11.
J Parkinsons Dis ; 14(4): 833-842, 2024.
Article in English | MEDLINE | ID: mdl-38728202

ABSTRACT

Background: Previous studies have demonstrated the importance of the locus coeruleus (LC) in sleep-wake regulation. Both essential tremor (ET) and Parkinson's disease (PD) share common sleep disorders, such as poor quality of sleep (QoS). LC pathology is a feature of both diseases. A question arises regarding the contribution of LC degeneration to the occurrence of poor QoS. Objective: To evaluate the association between LC impairment and sleep disorders in ET and PD patients. Methods: A total of 83 patients with ET, 124 with PD, and 83 healthy individuals were recruited and divided into ET/PD with/without poor QoS (Sle/NorET and Sle/NorPD) subgroups according to individual Pittsburgh Sleep Quality Index (PSQI) score. Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) and free-water imaging derived from diffusion MRI were performed. Subsequently, we evaluated the association between contrast-to-noise ratio of LC (CNRLC) and free-water value of LC (FWLC) with PSQI scores in ET and PD groups. Results: CNRLC was significantly lower in ET (p = 0.047) and PD (p = 0.018) than in healthy individuals, whereas no significant difference was found in FWLC among the groups. No significant differences were observed in CNR/FWLC between patients with/without sleep disorders after multiple comparison correction. No correlation was identified between CNR/FWLC and PSQI in ET and PD patients. Conclusions: LC degeneration was observed in both ET and PD patients, implicating its involvement in the pathophysiology of both diseases. Additionally, no significant association was observed between LC integrity and PSQI, suggesting that LC impairment might not directly relate to overall QoS.


Subject(s)
Essential Tremor , Locus Coeruleus , Parkinson Disease , Sleep Wake Disorders , Humans , Essential Tremor/physiopathology , Essential Tremor/complications , Essential Tremor/pathology , Locus Coeruleus/diagnostic imaging , Locus Coeruleus/pathology , Female , Male , Parkinson Disease/complications , Parkinson Disease/physiopathology , Parkinson Disease/diagnostic imaging , Aged , Middle Aged , Sleep Wake Disorders/etiology , Sleep Wake Disorders/physiopathology , Magnetic Resonance Imaging , Nerve Degeneration/pathology , Sleep Quality , Melanins
12.
Neurology ; 102(10): e209302, 2024 May.
Article in English | MEDLINE | ID: mdl-38662978

ABSTRACT

BACKGROUND AND OBJECTIVES: Sleep disorders are a common and important clinical feature in patients with autoimmune encephalitis (AE); however, they are poorly understood. We aimed to evaluate whether cardiopulmonary coupling (CPC), an electrocardiogram-based portable sleep monitoring technology, can be used to assess sleep disorders in patients with AE. METHODS: Patients fulfilling the diagnostic criteria of AE were age- and sex-matched with recruited healthy control subjects. All patients and subjects received CPC testing between August 2020 and December 2022. Demographic data, clinical information, and Pittsburgh Sleep Quality Index (PSQI) scores were collected from the medical records. Data analysis was performed using R language programming software. RESULTS: There were 60 patients with AE (age 26.0 [19.8-37.5] years, male 55%) and 66 healthy control subjects (age 30.0 [25.8-32.0] years, male 53%) included in this study. Compared with healthy subjects, patients with AE had higher PSQI scores (7.00 [6.00-8.00] vs 3.00 [2.00-4.00], p < 0.001), lower sleep efficiency (SE 80% [71%-87%] vs 92% [84%-95%], p < 0.001), lower percentage of high-frequency coupling (25% [14%-43%] vs 45% [38%-53%], p < 0.001), higher percentage of REM sleep (19% ± 9% vs 15% ± 7%, p < 0.001), higher percentage of wakefulness (W% 16% [11%-25%] vs 8% [5%-16%], p = 0.074), higher low-frequency to high-frequency ratio (LF/HF 1.29 [0.82-2.40] vs 0.91 [0.67-1.29], p = 0.001), and a higher CPC-derived respiratory disturbance index (9.78 [0.50-22.2] vs 2.95 [0.40-6.53], p < 0.001). Follow-up evaluation of 14 patients showed a decrease in the PSQI score (8.00 [6.00-9.00] vs 6.00 [5.00-7.00], p = 0.008), an increased SE (79% [69%-86%] vs 89% [76%-91%], p = 0.030), and a decreased W% (20% [11%-30%] vs 11% [8%-24], p = 0.035). Multiple linear regression indicated that SE (-7.49 [-9.77 to -5.21], p < 0.001) and LF/HF ratio (0.37 [0.13-0.6], p = 0.004) were independent factors affecting PSQI scores in patients with AE. DISCUSSION: Sleep disorders with autonomic dysfunction are common in patients with AE. Improvements in the PSQI score and SE precede the restoration of sleep microstructural disruption in the remission stage. CPC parameters may be useful in predicting sleep disorders in patients with AE.


Subject(s)
Encephalitis , Sleep Wake Disorders , Humans , Male , Female , Adult , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathology , Young Adult , Encephalitis/diagnosis , Encephalitis/complications , Encephalitis/physiopathology , Hashimoto Disease/complications , Hashimoto Disease/physiopathology , Hashimoto Disease/diagnosis , Electrocardiography/methods , Polysomnography/methods
13.
Article in Russian | MEDLINE | ID: mdl-38676671

ABSTRACT

Modern research raises the question of the potentially significant role of glymphatic dysfunction in the development of neurodegeneration and pathological aging. The exact molecular mechanisms are not yet fully understood, but there is ample evidence of a link between sleep deprivation and decreased clearance of ß-amyloid and other neurotoxin proteins that are associated with the development of neurodegenerative diseases, particularly Alzheimer's disease. The review analyzes current scientific information in this area of research, describes the latest scientific discoveries of the features of the glymphatic system, and also illustrates studies of markers that presumably indicate a deterioration in the glymphatic system. The relationship between sleep deprivation and pathophysiological mechanisms associated with neurodegenerative diseases is considered, and potential targets that can be used to treat or delay the development of these disorders are noted.


Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Glymphatic System , Sleep Wake Disorders , Humans , Alzheimer Disease/physiopathology , Alzheimer Disease/metabolism , Glymphatic System/physiopathology , Glymphatic System/metabolism , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/metabolism , Amyloid beta-Peptides/metabolism , Sleep Deprivation/physiopathology , Sleep Deprivation/complications , Sleep Deprivation/metabolism
14.
Ageing Res Rev ; 97: 102307, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38614368

ABSTRACT

Sleep is a highly intricate biological phenomenon, and its disorders play a pivotal role in numerous diseases. However, the specific regulatory mechanisms remain elusive. In recent years, the role of mitochondria in sleep disorders has gained considerable attention. Sleep deprivation not only impairs mitochondrial morphology but also decreases the number of mitochondria and triggers mitochondrial dysfunction. Furthermore, mitochondrial dysfunction has been implicated in the onset and progression of various sleep disorder-related neurological diseases, especially neurodegenerative conditions. Therefore, a greater understanding of the impact of sleep disorders on mitochondrial dysfunction may reveal new therapeutic targets for neurodegenerative diseases. In this review, we comprehensively summarize the recent key findings on the mechanisms underlying mitochondrial dysfunction caused by sleep disorders and their role in initiating or exacerbating common neurodegenerative diseases. In addition, we provide fresh insights into the diagnosis and treatment of sleep disorder-related diseases.


Subject(s)
Mitochondria , Neurodegenerative Diseases , Sleep Wake Disorders , Humans , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/physiopathology , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/complications , Sleep Wake Disorders/metabolism , Mitochondria/metabolism , Mitochondria/pathology , Animals , Mitochondrial Diseases/physiopathology , Mitochondrial Diseases/complications , Mitochondrial Diseases/metabolism
15.
Physiol Meas ; 45(5)2024 May 15.
Article in English | MEDLINE | ID: mdl-38653318

ABSTRACT

Objective.Sleep staging based on full polysomnography is the gold standard in the diagnosis of many sleep disorders. It is however costly, complex, and obtrusive due to the use of multiple electrodes. Automatic sleep staging based on single-channel electro-oculography (EOG) is a promising alternative, requiring fewer electrodes which could be self-applied below the hairline. EOG sleep staging algorithms are however yet to be validated in clinical populations with sleep disorders.Approach.We utilized the SOMNIA dataset, comprising 774 recordings from subjects with various sleep disorders, including insomnia, sleep-disordered breathing, hypersomnolence, circadian rhythm disorders, parasomnias, and movement disorders. The recordings were divided into train (574), validation (100), and test (100) groups. We trained a neural network that integrated transformers within a U-Net backbone. This design facilitated learning of arbitrary-distance temporal relationships within and between the EOG and hypnogram.Main results.For 5-class sleep staging, we achieved median accuracies of 85.0% and 85.2% and Cohen's kappas of 0.781 and 0.796 for left and right EOG, respectively. The performance using the right EOG was significantly better than using the left EOG, possibly because in the recommended AASM setup, this electrode is located closer to the scalp. The proposed model is robust to the presence of a variety of sleep disorders, displaying no significant difference in performance for subjects with a certain sleep disorder compared to those without.Significance.The results show that accurate sleep staging using single-channel EOG can be done reliably for subjects with a variety of sleep disorders.


Subject(s)
Electrooculography , Sleep Stages , Sleep Wake Disorders , Humans , Sleep Stages/physiology , Electrooculography/methods , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathology , Male , Female , Adult , Cohort Studies , Middle Aged , Signal Processing, Computer-Assisted , Neural Networks, Computer , Young Adult , Polysomnography
16.
Pediatr Neurol ; 155: 114-119, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38631079

ABSTRACT

BACKGROUND: The aim of this study was to investigate sleep habits, quality of life (QoL), and the relationship between them in children with epilepsy. METHODS: In this cross-sectional study, children aged two to 18 years being followed up for epilepsy were assessed using the Children's Sleep Habits Questionnaire (CSHQ) and the Pediatric Quality of Life Inventory (PedsQL). Pearson or Spearman correlation analysis was performed to examine the relationship between normally distributed and non-normally distributed variables, respectively. Linear regression analysis was used to examine independent variables associated with PedsQL total scale score. Level of significance was accepted as P < 0.05. RESULTS: The study included 112 children with a mean age of 10.5 ± 4.4 years (51.8% female). The frequency of poor sleep habits was 96.4%. There was a good level of agreement between children's and parents' PedsQL total, physical health, and psychosocial health scores (P < 0.001). Correlation analysis between QoL and sleep parameters revealed negative correlations between total sleep score and self-assessed PedsQL total scale, physical health, and psychosocial health scores (P < 0.05) and parent-assessed PedsQL total scale and psychosocial health scores (P < 0.05). The results of linear regression analysis indicated that the factors most significantly associated with lower QoL were high CSHQ total sleep score and exclusively daytime seizures (P < 0.001). CONCLUSIONS: It was found that children with epilepsy had poor sleep habits and low QoL and that poor sleep habits have a negative impact on QoL.


Subject(s)
Epilepsy , Quality of Life , Humans , Female , Male , Child , Cross-Sectional Studies , Epilepsy/physiopathology , Adolescent , Child, Preschool , Sleep Wake Disorders/etiology , Sleep Wake Disorders/physiopathology , Sleep/physiology , Surveys and Questionnaires , Habits
17.
Biol Psychol ; 188: 108790, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38580098

ABSTRACT

Given the high prevalence of anxiety disorders and their associated impairment, elucidating neural mechanisms related to these disorders has been increasingly prioritized. The error-related negativity (ERN) has been identified as a neural marker that indexes risk for anxiety across development. The ERN seems to confer risk for developing anxiety, especially in the context of stressful life events. The present study sought to examine sleep-related difficulties as another stressful factor that might impact the ERN. In a sample of 221 girls, aged 8 to 15 years old, we first examined the relationship between longer-term (i.e., over the past month) and shorter-term (i.e., over the past week) sleep difficulties and the ERN. We then investigated whether specific sleep difficulties uniquely predict the ERN. In exploratory analyses, we assessed whether sleep difficulties moderate the relationship between the ERN and anxiety. Results indicated that youth who report longer-term lower sleep duration, longer-term worse sleep, and shorter-term lower sleep duration on school days over the past week have a larger (i.e., more negative) ERN. Additionally, only shorter-term sleep duration on school days over the past week uniquely predicted the ERN. Finally, an elevated ERN predicted greater clinical anxiety in the context of longer-term sleep difficulties. Future studies should clarify the direction of these associations via longitudinal designs.


Subject(s)
Anxiety , Brain , Electroencephalography , Evoked Potentials , Humans , Female , Adolescent , Child , Anxiety/physiopathology , Brain/physiopathology , Evoked Potentials/physiology , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/psychology , Sleep/physiology , Reaction Time/physiology
18.
Twin Res Hum Genet ; 27(2): 97-104, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38505981

ABSTRACT

Women with twin pregnancies experience greater sleep disturbance compared to women with singleton pregnancies. The aims of this study were to explore the sleep quality in women with twin pregnancies and to compare their sleep dimensions with coetaneous single pregnancies. This was an observational study in which women were enrolled at the end of pregnancy in the Obstetric Service of Hospital La Paz (Spain). The women were classified as single (n = 143) or twin pregnancy (n = 62). Pregnant women responded to the Pittsburgh Sleep Quality Index to evaluate sleep quality, latency, duration, efficiency, perturbance, use of medication, and daytime dysfunction. The higher the index, the greater the alteration of sleep quality. Without statistical differences, a poor sleep quality was higher in women with single (66.7%) than women with twin pregnancies (22.8%). The good sleeper slept 6.8 h/day in single pregnancy and 7.3 h/day in twin pregnancy. The sleep perturbation and dysfunctionality were higher in women with twin than single pregnancies. The use of medication to sleep was significantly lower in women with twin than single pregnancies. In women with twin pregnancy, the body weight gain during first trimester had a positive correlation with worse sleep quality and sleep perturbations. Twin pregnancy needed more than 7 h/day to have a high sleep quality, showing greater sleep perturbations and daytime dysfunction than single pregnancies. The control of gestational body weight can improve the sleep quality, disturbances, and duration in twin gestations. Sleep screening during pregnancy would be necessary to handle sleep issues and increase benefits in twin gestational outcomes.


Subject(s)
Pregnancy, Twin , Sleep Quality , Humans , Female , Pregnancy , Adult , Spain/epidemiology , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/epidemiology , Pregnancy Complications/physiopathology
19.
Neurourol Urodyn ; 43(5): 1127-1133, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38511613

ABSTRACT

INTRODUCTION: Nocturia is a complex and multifactorial condition, associated with several genitourinary abnormalities as well as a host of conditions beyond the urinary tract, and thus often poses a significant diagnostic challenge in real-world practice. Sleep Disorders, Comorbidities, Actions, Lower Urinary Tract Dysfunction, and Medications, the so-called "Sleep C.A.L.M." factors, are five common causes of nocturia requiring judicious evaluation according to current consensus guidelines. This study aims to assess the prevalence of the Sleep C.A.L.M. factors in a nocturia clinical population. METHODS: Retrospective analysis of frequency-volume charts from men with ≥2 nocturnal voids as well as concurrent demographic, clinical, and medical history data to identify patients with each of the Sleep C.A.L.M. FACTORS: Comorbidities and medications were classified as a single group. RESULTS: A total of 213 subjects met the criteria for inclusion (median age 68.0 [63.5-75.5] years). The prevalence of 1) sleep disorders, 2) comorbidities and/or medication use, 3) actions (i.e., modifiable behaviors/lifestyle factors), and 4) lower urinary tract dysfunction was 31%, 31%, 19%, and 41%, respectively. Among included participants, 73% were found to have at least 1 Sleep C.A.L.M. factor, and 33% had multiple Sleep C.A.L.M. FACTORS: Results were similar upon stratification by age and nocturnal polyuria status. CONCLUSIONS: The Sleep C.A.L.M. factors are highly common among nocturia patients in the clinical urology setting. Although many of these factors are strongly associated with advanced age in community-based nocturia study samples, they appear common even among younger men in a nocturia patient population; the differential effect of age and individual Sleep C.A.L.M. factors on nocturia pathophysiology requires further investigation.


Subject(s)
Nocturia , Sleep Wake Disorders , Humans , Nocturia/epidemiology , Nocturia/physiopathology , Nocturia/diagnosis , Male , Aged , Middle Aged , Retrospective Studies , Prevalence , Sleep Wake Disorders/epidemiology , Sleep Wake Disorders/physiopathology , Sleep Wake Disorders/diagnosis , Veterans , Comorbidity , Risk Factors , Sleep
20.
Sleep ; 47(5)2024 May 10.
Article in English | MEDLINE | ID: mdl-38300526

ABSTRACT

Sleep problems are common in individuals with low back pain (LBP) and sleep restriction seems to be associated with impaired pain processing. Our objective was to investigate whether sleep is associated with future LBP outcomes (i.e. pain intensity, disability, and recovery) in adults. We conducted a systematic review of prospective cohort studies and secondary analyses of randomized controlled trials (registration-PROSPERO CRD42022370781). In December 2022, we searched the MEDLINE, Embase, CINAHL, and PsycINFO databases. Fourteen studies, totaling 19 170 participants were included. Thirteen studies were rated as having high risk of bias (QUIPS tool). We used vote-counting and meta-analysis approaches to synthesize the data. We found associations between baseline sleep with future pain intensity, recovery, and between changes in sleep with changes in pain intensity, changes in disability, and recovery. We further synthesized outcomes as "overall LBP improvement" outcomes. Baseline poor sleep was moderately associated with non-improvement in LBP in the long-very long term (OR 1.55, 95% CI: 1.39 to 1.73; three studies providing unadjusted effect sizes), and non-improvement in sleep was largely associated with non-improvement in LBP in the short-moderate term (OR 3.45, 95% CI: 2.54 to 4.69; four studies providing unadjusted effect sizes). We found no association between baseline sleep with future disability and overall LBP improvement in the short-moderate term. Therefore, sleep may be a prognostic factor for pain intensity and recovery from LBP. All findings were supported by low to very low-quality evidence. Better-conducted studies are needed to strengthen our certainty about the evidence.


Subject(s)
Low Back Pain , Randomized Controlled Trials as Topic , Low Back Pain/physiopathology , Humans , Prognosis , Prospective Studies , Sleep Wake Disorders/physiopathology , Sleep/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...